Show simple item record

dc.contributor.authorCampo, Gianluca
dc.contributor.authorPavasini, Rita
dc.contributor.authorMorciano, Giampaolo
dc.contributor.authorLincoff, Michael A.
dc.contributor.authorGibson, Michael C.
dc.contributor.authorKitakaze, Masafumi
dc.contributor.authorLonborg, Jacob
dc.contributor.authorAhluwalia, Amrita
dc.contributor.authorIshii, Hideki
dc.contributor.authorFrenneaux, Michael
dc.contributor.authorOvize, Michel
dc.contributor.authorGalvani, Marcello
dc.contributor.authorAtar, Dan
dc.contributor.authorIbanez, Borja
dc.contributor.authorCerisano, Giampaolo
dc.contributor.authorBiscaglia, Simone
dc.contributor.authorNeil, Brandon J.
dc.contributor.authorAsakura, Masanori
dc.contributor.authorEngstrom, Thomas
dc.contributor.authorJones, Daniel A.
dc.contributor.authorDawson, Dana
dc.contributor.authorFerrari, Roberto
dc.contributor.authorPinton, Paolo
dc.contributor.authorOttani, Filippo
dc.date.accessioned2017-09-07T09:00:54Z
dc.date.available2017-09-07T09:00:54Z
dc.date.issued2017-10
dc.identifier.citationCampo , G , Pavasini , R , Morciano , G , Lincoff , M A , Gibson , M C , Kitakaze , M , Lonborg , J , Ahluwalia , A , Ishii , H , Frenneaux , M , Ovize , M , Galvani , M , Atar , D , Ibanez , B , Cerisano , G , Biscaglia , S , Neil , B J , Asakura , M , Engstrom , T , Jones , D A , Dawson , D , Ferrari , R , Pinton , P & Ottani , F 2017 , ' Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention ' Data in brief , vol. 14 , pp. 197-205 . https://doi.org/10.1016/j.dib.2017.07.033en
dc.identifier.issn2352-3409
dc.identifier.otherPURE: 107769793
dc.identifier.otherPURE UUID: 55d0da79-7887-4f2f-a635-62a1b841aaf1
dc.identifier.otherPubMed: 28795098
dc.identifier.otherPubMedCentral: PMC5537426
dc.identifier.otherScopus: 85026382122
dc.identifier.urihttp://hdl.handle.net/2164/9274
dc.descriptionAcknowledgements Conflict of interest: Lincoff receives research support from Kai Pharmaceuticals; Gibson receives research support from Stealth pharmaceuticals; other authors do not declare conflict of interest. Funding: none. Transparency document. Supplementary material Transparency data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.dib.2017.07.033.en
dc.format.extent9en
dc.language.isoeng
dc.relation.ispartofData in briefen
dc.rights© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)en
dc.subjectJournal Articleen
dc.subjectReperfusion injuryen
dc.subjectMyocardial infarctionen
dc.subjectPCIen
dc.subjectCyclosporinen
dc.subjectNicorandilen
dc.subjectFollow-upen
dc.subjectR Medicine (General)en
dc.subject.lccR1en
dc.titleData on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary interventionen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen, Medical Sciences - Cardiovascular Groupen
dc.contributor.institutionUniversity of Aberdeen, Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen, Applied Medicineen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1016/j.dib.2017.07.033


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record